vs
Side-by-side financial comparison of Foghorn Therapeutics Inc. (FHTX) and TECHPRECISION CORP (TPCS). Click either name above to swap in a different company.
Foghorn Therapeutics Inc. is the larger business by last-quarter revenue ($9.2M vs $7.1M, roughly 1.3× TECHPRECISION CORP). TECHPRECISION CORP runs the higher net margin — -20.8% vs -234.3%, a 213.5% gap on every dollar of revenue. On growth, Foghorn Therapeutics Inc. posted the faster year-over-year revenue change (223.8% vs -6.9%). Over the past eight quarters, Foghorn Therapeutics Inc.'s revenue compounded faster (35.3% CAGR vs -9.2%).
Foghorn Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing novel therapies targeting the chromatin regulatory system to treat various types of cancer and other severe diseases. It advances a diverse pipeline of targeted drug candidates, conducting internal R&D and strategic partnerships to serve global patient populations.
TechPrecision Corp is a manufacturer of custom high-precision metal fabricated components and integrated systems, serving aerospace, defense, medical technology, renewable energy, and industrial end markets primarily across North America and Europe. It specializes in producing tight-tolerance, mission-critical parts that adhere to rigorous industry quality requirements.
FHTX vs TPCS — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $9.2M | $7.1M |
| Net Profit | $-21.7M | $-1.5M |
| Gross Margin | — | 5.4% |
| Operating Margin | -258.2% | -19.1% |
| Net Margin | -234.3% | -20.8% |
| Revenue YoY | 223.8% | -6.9% |
| Net Profit YoY | -11.1% | -84.4% |
| EPS (diluted) | $-0.35 | $-0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $9.2M | $7.1M | ||
| Q3 25 | $8.2M | $9.1M | ||
| Q2 25 | $7.6M | $7.4M | ||
| Q1 25 | $6.0M | $9.5M | ||
| Q4 24 | $2.9M | $7.6M | ||
| Q3 24 | $7.8M | $8.9M | ||
| Q2 24 | $6.9M | $8.0M | ||
| Q1 24 | $5.0M | $8.6M |
| Q4 25 | $-21.7M | $-1.5M | ||
| Q3 25 | $-15.8M | $825.0K | ||
| Q2 25 | $-17.9M | $-597.0K | ||
| Q1 25 | $-18.8M | $112.0K | ||
| Q4 24 | $-19.5M | $-799.0K | ||
| Q3 24 | $-19.1M | $-601.0K | ||
| Q2 24 | $-23.0M | $-1.5M | ||
| Q1 24 | $-25.0M | $-5.1M |
| Q4 25 | — | 5.4% | ||
| Q3 25 | — | 27.1% | ||
| Q2 25 | — | 14.0% | ||
| Q1 25 | — | 22.0% | ||
| Q4 24 | — | 13.0% | ||
| Q3 24 | — | 11.3% | ||
| Q2 24 | — | 3.0% | ||
| Q1 24 | — | 14.3% |
| Q4 25 | -258.2% | -19.1% | ||
| Q3 25 | -226.9% | 10.4% | ||
| Q2 25 | -279.2% | -6.3% | ||
| Q1 25 | -385.0% | 3.9% | ||
| Q4 24 | -840.5% | -9.1% | ||
| Q3 24 | -305.5% | -5.5% | ||
| Q2 24 | -386.6% | -16.8% | ||
| Q1 24 | -558.3% | -28.6% |
| Q4 25 | -234.3% | -20.8% | ||
| Q3 25 | -194.4% | 9.1% | ||
| Q2 25 | -237.3% | -8.1% | ||
| Q1 25 | -316.4% | 1.2% | ||
| Q4 24 | -682.9% | -10.5% | ||
| Q3 24 | -244.9% | -6.7% | ||
| Q2 24 | -333.6% | -18.3% | ||
| Q1 24 | -495.4% | -59.5% |
| Q4 25 | $-0.35 | $-0.15 | ||
| Q3 25 | $-0.25 | $0.08 | ||
| Q2 25 | $-0.28 | $-0.06 | ||
| Q1 25 | $-0.30 | $0.01 | ||
| Q4 24 | $-0.23 | $-0.08 | ||
| Q3 24 | $-0.31 | $-0.06 | ||
| Q2 24 | $-0.45 | $-0.16 | ||
| Q1 24 | $-0.59 | $-0.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $80.9M | $50.0K |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-108.5M | $8.0M |
| Total Assets | $198.1M | $32.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $80.9M | $50.0K | ||
| Q3 25 | $89.3M | $220.0K | ||
| Q2 25 | $72.6M | $143.0K | ||
| Q1 25 | $61.0M | $195.0K | ||
| Q4 24 | $55.5M | $165.0K | ||
| Q3 24 | $57.7M | $132.0K | ||
| Q2 24 | $138.9M | $44.8K | ||
| Q1 24 | $79.3M | $138.0K |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $3.0K | ||
| Q4 24 | — | $19.0K | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $-108.5M | $8.0M | ||
| Q3 25 | $-89.7M | $9.1M | ||
| Q2 25 | $-76.7M | $8.2M | ||
| Q1 25 | $-61.7M | $8.7M | ||
| Q4 24 | $-45.5M | $8.1M | ||
| Q3 24 | $-28.3M | $8.9M | ||
| Q2 24 | $-14.3M | $7.9M | ||
| Q1 24 | $-97.5M | $7.8M |
| Q4 25 | $198.1M | $32.8M | ||
| Q3 25 | $205.0M | $33.8M | ||
| Q2 25 | $226.2M | $32.1M | ||
| Q1 25 | $258.7M | $33.5M | ||
| Q4 24 | $284.0M | $32.2M | ||
| Q3 24 | $308.4M | $35.0M | ||
| Q2 24 | $328.6M | $35.7M | ||
| Q1 24 | $255.0M | $34.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.00× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-22.3M | $183.0K |
| Free Cash FlowOCF − Capex | — | $-827.0K |
| FCF MarginFCF / Revenue | — | -11.7% |
| Capex IntensityCapex / Revenue | 0.0% | 14.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-4.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-22.3M | $183.0K | ||
| Q3 25 | $-18.9M | $-1.1M | ||
| Q2 25 | $-21.0M | $646.0K | ||
| Q1 25 | $-24.0M | $396.0K | ||
| Q4 24 | $-24.5M | $-570.0K | ||
| Q3 24 | $-21.0M | $-532.0K | ||
| Q2 24 | $-25.5M | $107.0K | ||
| Q1 24 | $-29.3M | $-452.0K |
| Q4 25 | — | $-827.0K | ||
| Q3 25 | — | $-2.1M | ||
| Q2 25 | $-21.0M | $-604.0K | ||
| Q1 25 | $-24.0M | $-930.0K | ||
| Q4 24 | $-25.0M | $-1.7M | ||
| Q3 24 | $-21.3M | $-2.0M | ||
| Q2 24 | $-25.6M | $-94.0K | ||
| Q1 24 | $-29.4M | $-900.0K |
| Q4 25 | — | -11.7% | ||
| Q3 25 | — | -22.9% | ||
| Q2 25 | -278.2% | -8.2% | ||
| Q1 25 | -403.2% | -9.8% | ||
| Q4 24 | -875.3% | -22.9% | ||
| Q3 24 | -273.0% | -21.8% | ||
| Q2 24 | -371.0% | -1.2% | ||
| Q1 24 | -583.1% | -10.5% |
| Q4 25 | 0.0% | 14.2% | ||
| Q3 25 | 0.0% | 11.0% | ||
| Q2 25 | 0.3% | 16.9% | ||
| Q1 25 | 0.5% | 14.0% | ||
| Q4 24 | 16.8% | 15.4% | ||
| Q3 24 | 4.0% | 15.9% | ||
| Q2 24 | 0.2% | 2.5% | ||
| Q1 24 | 2.0% | 5.2% |
| Q4 25 | — | — | ||
| Q3 25 | — | -1.31× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 3.54× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FHTX
Segment breakdown not available.
TPCS
| Defense | $6.7M | 94% |
| Other | $410.0K | 6% |
